查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
牙周治療設備的全球市場：按產品、疾病、治療、最終用戶、地區 - 預測到 2030 年
市場調查報告書
商品編碼
1608633

牙周治療設備的全球市場：按產品、疾病、治療、最終用戶、地區 - 預測到 2030 年

Periodontal Disease Treatment Market By Disease Type (Gingivitis, Aggressive Periodontitis, Chronic Periodontitis), Treatment Type (Flap surgery, Root Planning, Bone Grafting,), End User (Dental Hospitals & Dental Clinics) - Global Forecast to 2030
出版日期: | 出版商: MarketsandMarkets | 英文 280 Pages | 訂單完成後即時交付

價格

全球牙周治療設備市場規模預計將從 2024 年的 25.8 億美元增至 2030 年的 36.3 億美元，預測期內複合年成長率為 5.9%。

這是由於人們對口腔健康與整體健康之間聯繫的認知不斷提高，導致患者和醫療保健提供者都專注於牙周護理。政府主導的口腔衛生宣傳活動的增加以及牙科保險覆蓋範圍的擴大也推動了這個市場的發展。牙科醫療保健基礎設施的增加，特別是在新興經濟體，進一步推動了該市場的發展。此外，微創手術、生物製藥和新藥發現的採用正在提高治療效果，進一步推動牙周病市場參與企業在 2024-2030 年預測期內的成長。

調查範圍
調查年份 2024-2030
基準年 2023年
預測期 2024-2030
考慮單位 金額（百萬美元/十億美元）
按細分市場 按產品、疾病、治療、最終用戶、地區
目標區域 北美、歐洲、亞太地區、中東、非洲

按疾病類型分類，預計在預測期內，慢性牙周炎細分市場將在牙周治療設備市場中佔據第二大佔有率。其背景是患有牙周病的老年人數量不斷增加。由於慢性牙周炎多見於老年患者，因此這種疾病將變得越來越常見。對口腔健康與糖尿病和心血管疾病等全身性疾病之間關係的認知不斷提高，患者對預防和治療護理的需求不斷增加，從而導致診斷和後續治療的引入增加。

依治療類型分類，牙周治療市場分為非手術治療、皮瓣手術、軟組織移植、骨移植、引導組織再生等治療。引導組織再生領域預計將以最高的複合年成長率成長，因為它在牙周病治療的研發 (R&D) 中發揮著至關重要的作用。生物材料和組織工程的進步促進了新型、更有效率和生物相容性膜的開發，改善了治療效果。 GTR 程序擴大被牙科專業人士採用，並且由於專業設備的培訓和可用性的增加而變得更加可行。各地區優惠的報銷政策以及美容牙科的普及也對GTR市場的高成長起到了重要作用。

全球牙周治療設備市場分為五個主要地區：北美、歐洲、亞太地區、拉丁美洲、中東和非洲。歐洲是牙周治療設備市場的第二大區域市場，而亞太市場預計在預測期內將以最高的複合年成長率成長。

該報告研究了全球牙周治療設備市場，並按產品、疾病、治療、最終用戶、地區和進入市場的公司概況總結了趨勢。

目錄

第1章簡介

第2章調查方法

第3章執行摘要

第 4 章重要考察

第5章市場概況

  • 介紹
  • 市場動態
  • 產業動態
  • 技術分析
  • 價值鏈分析
  • 生態系圖
  • 供應鏈分析
  • 監管分析
  • 專利分析
  • 貿易分析
  • 影響客戶業務的趨勢/干擾
  • 牙周病治療的鄰近市場
  • 案例研究分析
  • 波特五力分析
  • 2024年重大會議和活動
  • 價格分析
  • 主要相關人員和採購標準
  • 牙周病治療市場未滿足的需求
  • 投資金籌措場景
  • 主要國家牙齦炎盛行率
  • 主要國家手術量分析

第6章 牙周病治療市場（分產品）

  • 介紹
  • 裝置
  • 消耗品
  • 藥品

第7章 牙周病治療市場（依病種）

  • 介紹
  • 牙齦炎
  • 慢性牙周炎
  • 嚴重牙周炎
  • 其他

第8章 牙周病治療市場（依治療方式）

  • 介紹
  • 非手術治療
  • 皮瓣手術/袋縮小術
  • 軟組織移植
  • 骨移植
  • 引導組織再生
  • 其他

第9章 牙周病治療市場（依最終使用者）

  • 介紹
  • 醫院
  • 私人及 DSO 診所
  • 學術研究所

第10章 牙周病治療市場（分地區）

  • 介紹
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲
  • 海灣合作理事會國家

第11章競爭格局

  • 介紹
  • 主要參與企業的策略/優勢
  • 2019-2023年收益分析
  • 2023 年市場佔有率分析
  • 企業評估矩陣：主要參與企業，2023
  • 企業評估矩陣：Start-Ups/小型企業，2023 年
  • 公司評價及財務指標
  • 品牌/產品比較
  • 研究開發費用
  • 競爭場景

第12章 公司簡介

  • 主要參與企業
    • DENTSPLY SIRONA
    • ENVISTA HOLDINGS CORPORATION
    • INSTITUT STRAUMANN AG
    • HENRY SCHEIN, INC.
    • BIOLASE, INC.
    • GEISTLICH PHARMA AG
    • J. MORITA CORP.
    • NAKANISHI INC.
    • A-DEC INC.
    • RTI SURGICAL
    • YOSHIDA DENTAL MFG.CO. LTD.
    • KEYSTONE DENTAL INC.
    • ULTRADENT PRODUCTS, INC.
    • BEGO GMBH & CO. KG
    • DENTALEZ INC.
    • PARKELL, INC.
  • 其他公司
    • MILLENNIUM DENTAL TECHNOLOGIES INC.
    • BRASSELER USA
    • AMD LASERS
    • NOVA INSTRUMENTS
    • BOTISS BIOMATERIALS GMBH
    • CONVERGENT DENTAL
    • NOVABONE
    • REGENITY
    • HANNOX INTERNATIONAL CORP.

第13章附錄

Product Code: MD 9220

The global Periodontal disease treatment Equipment market is projected to reach USD 3.63 billion by 2030 from USD 2.58 billion in 2024, at a CAGR of 5.9% during the forecast period. This is due to increased awareness about the connection between oral health and overall systemic health, bringing the focus of both the patients and healthcare provider towards periodontal care. Increased government-driven campaigns to promote hygiene in the oral cavity and increased provision of dental insurance coverage have also added momentum towards this market. The increase in dental care infrastructures, especially in developing economies, is further fueling this market. In addition, the adoption of minimally invasive procedures and biologics as well as the discovery of new drugs has increased the efficacy of treatment, adding more fuel to the growth of the periodontal disease market players over the forecast period of 2024-2030.

Scope of the Report
Years Considered for the Study2024-2030
Base Year2023
Forecast Period2024-2030
Units ConsideredValue (USD Million/Billion)
SegmentsBy Disease Type, Treatment Type, End User, and Region
Regions coveredNorth America, Europe, APAC, LATAM, and MEA

"The chronic periodontitis segment of periodontal disease treatment market to hold second largest position forecast period."

Based on the disease type, the chronic periodontitis segment is anticipated to hold second largest share position during forecast period in periodontal disease treatment equipment market. This is due to increasing number of older populations are suffering from periodontal diseases. The condition will become increasingly common since chronic periodontitis is often found in older patients. Enhanced awareness regarding the relationship between oral health and systemic conditions, such as diabetes mellitus and cardiovascular disease, is generating a greater demand among patients to receive preventive and therapeutic care, which is increasing diagnoses and subsequent treatment adoption.

"The guided tissue regeneration segment is the fastest growing segment in periodontal disease treatment market."

Based on treatment type, the periodontal disease treatment market is segmented into non-surgical treatment, flap surgery, soft tissue graft, bone grafting, guided tissue regeneration and other treatments. The guided tissue regeneration segment is expected to grow at the highest CAGR due to its pivotal role in periodontal disease treatment research and development (R&D). Advances in biomaterials and tissue engineering have been made, leading to newer and more efficient and biocompatible membranes with better outcomes. GTR procedures are increasingly being adopted by dental professionals, and their growing training and availability of specialized equipment have made it highly potential. Favorable reimbursement policies in different regions coupled with an upsurge of cosmetic dentistry have also played an important role in the high growth rate of the GTR market.

"Europe accounted for the second largest share of the periodontal disease treatment market by region."

The global periodontal disease treatment equipment market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Europe is the second largest regional market for periodontal disease treatment equipment, whereas the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period.

Europe holds the second-largest position in the periodontal disease treatment equipment market. The region has a well-established health infrastructure which provides better access to advanced dental care. Moreover, the significant rise in the geriatric population, which is more prone to periodontal diseases, covers the majority of the treatments required in Europe. The high awareness of oral health and preventive care services available in European countries further spur the expansion of this market. Favorable government policies, and reimbursement frameworks for dental care treatments, along with a high dental insurance coverage among the patients, supports them toward getting periodontal treatments. Ongoing research and development in dental technologies and biomaterials, including countries like Germany and Switzerland, also support this expansion in this region.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1-40%, Tier 2-30%, and Tier 3- 30%
  • By Designation: Directors-50%, Managers-30% and Others-20%
  • By Region: North America-38%, Europe-26%, Asia Pacific-15%, Latin America-11%, Middle East & Africa- 7%, GCC Countries- 3%

The major players operating in the periodontal disease treatment equipment market market are DENTSPLY SIRONA Inc. (US), Envista Holdings Corporation (US), A-dec Inc. (US), J. MORITA CORP. (Japan), Straumann Group (Switzerland), BIOLASE, Inc. (US), BEGO GmbH & Co. KG (Germany), Ultradent Products, Inc. (US), Yoshida Dental MFG. Co., Ltd. (Japan), Nakanishi Inc. (Japan), DentalEZ, Inc. (US), Geistlich Pharma AG (Switzerland), Nova Instruments (UK), NewTom (Italy), Millennium Dental Technologies, Inc. (US), PreXion, Inc. (Japan), Brasseler USA (US), AMD Lasers (US), and Bien-Air Dental (US).

Research Coverage

This report studies the periodontal disease treatment equipment market based on disease type, streatment type, end user and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:

  • Analysis of Key divers( Development of technologically advanced solutions, Rise in oral health disorders, Rising demand for advanced cosmetic dental procedures, Growing market for dental tourism in emerging countries restraints (High cost of dental imaging systems and lack of reimbursement for dental procedures, opportunity (Impact of DSOs on dental industry, Increasing number of dental laboratories investing in CAD/CAM technologies and Growing focus on emerging markets)
  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the periodontal disease treatment market
  • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the periodontal disease treatment market
  • Market Development: Comprehensive information on lucrative emerging regions
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the periodontal disease treatment market
  • Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKET SEGMENTATION
    • 1.3.2 INCLUSIONS & EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
  • 1.4 MARKET STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
  • 2.2 MARKET SIZE ESTIMATION
  • 2.3 MARKET BREAKDOWN & DATA TRIANGULATION
  • 2.4 MARKET SHARE ASSUMPTIONS
  • 2.5 RISK ASSESSMENT
  • 2.6 RESEARCH LIMITATIONS
    • 2.6.1 METHODOLOGY-RELATED LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 PERIODONTAL DISEASE TREATMENT MARKET OVERVIEW
  • 4.2 ASIA PACIFIC: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER & COUNTRY (2023)
  • 4.3 PERIODONTAL DISEASE TREATMENT MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • 4.4 REGIONAL MIX: PERIODONTAL DISEASE TREATMENT MARKET (2024-2030)

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing prevalence of oral disorders
      • 5.2.1.2 Rising cases of edentulism
      • 5.2.1.3 Emergence of innovative dental treatment procedures
      • 5.2.1.4 Expanding market for dental tourism in emerging economies
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High cost of advanced treatments and inadequate reimbursements for dental procedures
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Impact of DSOs on dental industry
      • 5.2.3.2 Growing awareness about oral health
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Shortage of skilled dental practitioners
  • 5.3 INDUSTRY TRENDS
    • 5.3.1 INCREASING PREFERENCE OF MINIMALLY INVASIVE DENTAL PROCEDURES
    • 5.3.2 MARKET CONSOLIDATION
    • 5.3.3 DENTAL INSURANCE IN US
  • 5.4 TECHNOLOGY ANALYSIS
    • 5.4.1 KEY TECHNOLOGIES
      • 5.4.1.1 3D printers
      • 5.4.1.2 Artificial intelligence
    • 5.4.2 ADJACENT TECHNOLOGIES
      • 5.4.2.1 Virtual reality
      • 5.4.2.2 Laser dentistry
  • 5.5 VALUE CHAIN ANALYSIS
  • 5.6 ECOSYSTEM MAP
  • 5.7 SUPPLY CHAIN ANALYSIS
  • 5.8 REGULATORY ANALYSIS
    • 5.8.1 REGULATORY LANDSCAPE
      • 5.8.1.1 US
      • 5.8.1.2 EU
      • 5.8.1.3 China
    • 5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.9 PATENT ANALYSIS
    • 5.9.1 PATENT PUBLICATION TRENDS FOR PERIODONTAL DISEASE TREATMENT
    • 5.9.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
  • 5.10 TRADE ANALYSIS
  • 5.11 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.12 ADJACENT MARKETS FOR PERIODONTAL DISEASE TREATMENT
  • 5.13 CASE STUDY ANALYSIS
    • 5.13.1 CASE STUDY 1: INNOVATION TRACKING, TECHNOLOGY ASSESSMENT, AND PRODUCT LAUNCHES IN ANTIMICROBIAL AGENTS & COATING SUBSTANCES FOR DENTAL IMPLANTS
    • 5.13.2 CASE STUDY 2: CUSTOMIZED STUDY FOR MEA
    • 5.13.3 CASE STUDY 3: CUSTOMIZED STUDY FOR LATIN AMERICA
  • 5.14 PORTER'S FIVE FORCES ANALYSIS
    • 5.14.1 THREAT OF NEW ENTRANTS
    • 5.14.2 THREAT OF SUBSTITUTES
    • 5.14.3 BARGAINING POWER OF SUPPLIERS
    • 5.14.4 BARGAINING POWER OF BUYERS
    • 5.14.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.15 KEY CONFERENCES & EVENTS, 2024
  • 5.16 PRICING ANALYSIS
    • 5.16.1 AVERAGE COST OF PERIODONTAL DISEASE TREATMENT SYSTEMS (2021-2023) (USD)
    • 5.16.2 AVERAGE COST RANGE OF PERIODONTAL DISEASE TREATMENT, BY REGION (2021-2023) (USD)
    • 5.16.3 AVERAGE SELLING PRICE OF PERIODONTAL DISEASE TREATMENT, BY PRODUCT TYPE
  • 5.17 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.17.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.17.2 BUYING CRITERIA
  • 5.18 UNMET NEEDS IN PERIODONTAL DISEASE TREATMENT MARKET
  • 5.19 INVESTMENT & FUNDING SCENARIO
  • 5.20 PREVALENCE OF GINGIVAL CASES IN KEY COUNTRIES
  • 5.21 ANALYSIS OF TOTAL NUMBER OF SURGERIES IN KEY COUNTRIES

6 PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
  • 6.2 EQUIPMENT
    • 6.2.1 GROWING PREFERENCE FOR MIS PROCEDURES TO DRIVE MARKET
  • 6.3 CONSUMABLES
    • 6.3.1 RECURRING NATURE & FREQUENT PURCHASE TO PROPEL MARKET
  • 6.4 MEDICATION
    • 6.4.1 GROWING AWARENESS OF ORAL HEALTH AND IMPROVEMENTS IN ANTIBIOTICS TO SUPPORT MARKET

7 PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE

  • 7.1 INTRODUCTION
  • 7.2 GINGIVITIS
    • 7.2.1 ACUTE GINGIVITIS
      • 7.2.1.1 Prevalence in children and adolescents to drive market
    • 7.2.2 RECURRENT GINGIVITIS
      • 7.2.2.1 Recurrent cases of bacterial infection due to poor oral hygiene to fuel market
    • 7.2.3 CHRONIC GINGIVITIS
      • 7.2.3.1 Prolonged inflammation of gums to support market growth
  • 7.3 CHRONIC PERIODONTITIS
    • 7.3.1 INCREASING CASES OF EDENTULISM TO FUEL MARKET
  • 7.4 AGGRESSIVE PERIODONTITIS
    • 7.4.1 RAPID TOOTH LOSS AND UNDERLYING HEALTH CONDITIONS TO CONTRIBUTE TO MARKET GROWTH
  • 7.5 OTHER DISEASES

8 PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT

  • 8.1 INTRODUCTION
  • 8.2 NON-SURGICAL TREATMENT
    • 8.2.1 SCALING
      • 8.2.1.1 Ability to inhibit bacterial infection to fuel uptake
    • 8.2.2 ROOT PLANING
      • 8.2.2.1 Reduction of gingival pockets to support market growth
    • 8.2.3 MEDICATION THERAPY
      • 8.2.3.1 Topical therapy
        • 8.2.3.1.1 Uptake of antimicrobial gels and mouth rinses to drive market
      • 8.2.3.2 Systemic therapy
        • 8.2.3.2.1 Utilization of host-modulating agents and antibiotics to drive market
  • 8.3 FLAP SURGERY/POCKET REDUCTION THERAPY
    • 8.3.1 COMMON SURGICAL PROCEDURE FOR ADVANCED PERIODONTAL DISEASES TO DRIVE MARKET
  • 8.4 SOFT TISSUE GRAFT
    • 8.4.1 PREVALENCE OF GINGIVAL RECESSION TO FUEL UPTAKE
  • 8.5 BONE GRAFTING
    • 8.5.1 GROWING FOCUS ON REGENERATION OF BONES TO FUEL UPTAKE
  • 8.6 GUIDED TISSUE REGENERATION
    • 8.6.1 HIGH SUCCESS RATE TO PROPEL MARKET
  • 8.7 OTHER TREATMENTS

9 PERIODONTAL DISEASE TREATMENT MARKET, BY END USER

  • 9.1 INTRODUCTION
  • 9.2 HOSPITALS
    • 9.2.1 AVAILABILITY OF ADVANCED EQUIPMENT FOR DENTISTRY AND GROWING FOCUS ON DENTAL TOURISM TO PROPEL MARKET
  • 9.3 PRIVATE & DSO CLINICS
    • 9.3.1 INCREASING ESTABLISHMENT OF PRIVATE PRACTICES TO DRIVE MARKET
  • 9.4 ACADEMIC & RESEARCH INSTITUTES
    • 9.4.1 R&D FUNDING INITIATIVES TO SUPPORT MARKET GROWTH

10 PERIODONTAL DISEASE TREATMENT MARKET, BY REGION

  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    • 10.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK
    • 10.2.2 US
      • 10.2.2.1 Favorable reimbursement policies for dental procedures to drive market
    • 10.2.3 CANADA
      • 10.2.3.1 Rising incidence of dental caries to drive market
  • 10.3 EUROPE
    • 10.3.1 EUROPE: MACROECONOMIC OUTLOOK
    • 10.3.2 GERMANY
      • 10.3.2.1 Hub for advanced dentistry technologies to propel market
    • 10.3.3 FRANCE
      • 10.3.3.1 Favorable government healthcare policies to fuel uptake
    • 10.3.4 UK
      • 10.3.4.1 Increasing incidence of dental disorders to drive market
    • 10.3.5 ITALY
      • 10.3.5.1 Low-cost dental treatments to support market growth
    • 10.3.6 SPAIN
      • 10.3.6.1 Privatization of dental clinics and uptake of advanced technologies to support market growth
    • 10.3.7 REST OF EUROPE
  • 10.4 ASIA PACIFIC
    • 10.4.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK
    • 10.4.2 CHINA
      • 10.4.2.1 Growing prevalence of dental diseases to drive market growth in China
    • 10.4.3 JAPAN
      • 10.4.3.1 Rising geriatric population and favorable reimbursement scenario to support market growth
    • 10.4.4 INDIA
      • 10.4.4.1 Expansion of dentistry and growing awareness of oral hygiene to drive market
    • 10.4.5 AUSTRALIA
      • 10.4.5.1 Favorable government initiatives and growing prevalence of dental diseases to drive market
    • 10.4.6 SOUTH KOREA
      • 10.4.6.1 Increasing cases of edentulism to fuel uptake
    • 10.4.7 REST OF ASIA PACIFIC
  • 10.5 LATIN AMERICA
    • 10.5.1 LATIN AMERICA: MACROECONOMIC OUTLOOK
    • 10.5.2 MEXICO
      • 10.5.2.1 Growth in dental tourism to drive market
    • 10.5.3 BRAZIL
      • 10.5.3.1 Trend of cosmetic dentistry to propel market
    • 10.5.4 ARGENTINA
      • 10.5.4.1 increasing use of CAD/CAM systems to support market growth
    • 10.5.5 REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 RISING AWARENESS ABOUT DENTAL HYGIENE TO SUPPORT MARKET GROWTH
    • 10.6.2 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK
  • 10.7 GCC COUNTRIES
    • 10.7.1 GROWING DEMAND FOR PERSONALIZED DENTISTRY TO DRIVE MARKET
    • 10.7.2 GCC COUNTRIES: MACROECONOMIC OUTLOOK

11 COMPETITIVE LANDSCAPE

  • 11.1 INTRODUCTION
  • 11.2 KEY PLAYER STRATEGY/RIGHT TO WIN
    • 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PERIODONTAL DISEASE TREATMENT MARKET
  • 11.3 REVENUE ANALYSIS, 2019-2023
  • 11.4 MARKET SHARE ANALYSIS, 2023
  • 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE PLAYERS
    • 11.5.4 PARTICIPANTS
    • 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 11.5.5.1 Company footprint
      • 11.5.5.2 Region footprint
      • 11.5.5.3 Product footprint
      • 11.5.5.4 Disease footprint
      • 11.5.5.5 Treatment footprint
      • 11.5.5.6 End-user footprint
  • 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 11.6.1 PROGRESSIVE COMPANIES
    • 11.6.2 RESPONSIVE COMPANIES
    • 11.6.3 DYNAMIC COMPANIES
    • 11.6.4 STARTING BLOCKS
    • 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  • 11.7 COMPANY VALUATION & FINANCIAL METRICS
    • 11.7.1 FINANCIAL METRICS
    • 11.7.2 COMPANY VALUATION
  • 11.8 BRAND/PRODUCT COMPARISON
  • 11.9 R&D EXPENDITURE
  • 11.10 COMPETITIVE SCENARIO
    • 11.10.1 PRODUCT LAUNCHES & APPROVALS
    • 11.10.2 DEALS
    • 11.10.3 EXPANSIONS

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
    • 12.1.1 DENTSPLY SIRONA
      • 12.1.1.1 Business overview
      • 12.1.1.2 Products offered
      • 12.1.1.3 Recent developments
        • 12.1.1.3.1 Product launches
        • 12.1.1.3.2 Deals
      • 12.1.1.4 MnM view
        • 12.1.1.4.1 Key strengths
        • 12.1.1.4.2 Strategic choices
        • 12.1.1.4.3 Weaknesses & competitive threats
    • 12.1.2 ENVISTA HOLDINGS CORPORATION
      • 12.1.2.1 Business overview
      • 12.1.2.2 Products offered
      • 12.1.2.3 Recent developments
        • 12.1.2.3.2 Product approvals
        • 12.1.2.3.3 Deals
      • 12.1.2.4 MnM view
        • 12.1.2.4.1 Key strengths
        • 12.1.2.4.2 Strategic choices
        • 12.1.2.4.3 Weaknesses & competitive threats
    • 12.1.3 INSTITUT STRAUMANN AG
      • 12.1.3.1 Business overview
      • 12.1.3.2 Products offered
      • 12.1.3.3 Recent developments
        • 12.1.3.3.1 Product launches
        • 12.1.3.3.2 Deals
        • 12.1.3.3.3 Expansions
      • 12.1.3.4 MnM view
        • 12.1.3.4.1 Key strengths
        • 12.1.3.4.2 Strategic choices
        • 12.1.3.4.3 Weaknesses & competitive threats
    • 12.1.4 HENRY SCHEIN, INC.
      • 12.1.4.1 Business overview
      • 12.1.4.2 Products offered
      • 12.1.4.3 Recent developments
        • 12.1.4.3.1 Deals
      • 12.1.4.4 MnM view
        • 12.1.4.4.1 Key strengths
        • 12.1.4.4.2 Strategic choices
        • 12.1.4.4.3 Weaknesses & competitive threats
    • 12.1.5 BIOLASE, INC.
      • 12.1.5.1 Business overview
      • 12.1.5.2 Products offered
      • 12.1.5.3 Recent developments
        • 12.1.5.3.1 Product launches
    • 12.1.6 GEISTLICH PHARMA AG
      • 12.1.6.1 Business overview
      • 12.1.6.2 Products offered
    • 12.1.7 J. MORITA CORP.
      • 12.1.7.1 Business overview
      • 12.1.7.2 Products offered
      • 12.1.7.3 Recent developments
        • 12.1.7.3.1 Product launches
        • 12.1.7.3.2 Deals
    • 12.1.8 NAKANISHI INC.
      • 12.1.8.1 Business overview
      • 12.1.8.2 Products offered
    • 12.1.9 A-DEC INC.
      • 12.1.9.1 Business overview
      • 12.1.9.2 Products offered
    • 12.1.10 RTI SURGICAL
      • 12.1.10.1 Business overview
      • 12.1.10.2 Products offered
      • 12.1.10.3 Recent developments
        • 12.1.10.3.1 Deals
    • 12.1.11 YOSHIDA DENTAL MFG.CO. LTD.
      • 12.1.11.1 Business overview
      • 12.1.11.2 Products offered
    • 12.1.12 KEYSTONE DENTAL INC.
      • 12.1.12.1 Business overview
      • 12.1.12.2 Products offered
      • 12.1.12.3 Recent developments
        • 12.1.12.3.1 Deals
    • 12.1.13 ULTRADENT PRODUCTS, INC.
      • 12.1.13.1 Business overview
      • 12.1.13.2 Products offered
    • 12.1.14 BEGO GMBH & CO. KG
      • 12.1.14.1 Business overview
      • 12.1.14.2 Products offered
      • 12.1.14.3 Recent developments
        • 12.1.14.3.1 Deals
    • 12.1.15 DENTALEZ INC.
      • 12.1.15.1 Business overview
      • 12.1.15.2 Products offered
      • 12.1.15.3 Recent developments
        • 12.1.15.3.1 Product launches
    • 12.1.16 PARKELL, INC.
      • 12.1.16.1 Business overview
      • 12.1.16.2 Products offered
      • 12.1.16.3 Recent developments
        • 12.1.16.3.1 Product launches
  • 12.2 OTHER PLAYERS
    • 12.2.1 MILLENNIUM DENTAL TECHNOLOGIES INC.
    • 12.2.2 BRASSELER USA
    • 12.2.3 AMD LASERS
    • 12.2.4 NOVA INSTRUMENTS
    • 12.2.5 BOTISS BIOMATERIALS GMBH
    • 12.2.6 CONVERGENT DENTAL
    • 12.2.7 NOVABONE
    • 12.2.8 REGENITY
    • 12.2.9 HANNOX INTERNATIONAL CORP.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 CURRENCY CONVERSION RATE, 2019-2023 (UNIT OF USD)
  • TABLE 2 PERIODONTAL DISEASE TREATMENT MARKET: RISK ASSESSMENT ANALYSIS
  • TABLE 3 INCREASE IN GERIATRIC POPULATION, BY COUNTRY (2022)
  • TABLE 4 AVERAGE PROCEDURAL COSTS IN TOP TEN DENTAL TOURISM DESTINATIONS (USD)
  • TABLE 5 LIST OF RECENT DEALS BY PRIVATE EQUITIES IN US, 2020-2023
  • TABLE 6 PER CAPITA NATIONAL INCOME, 2000-2020 (USD)
  • TABLE 7 KEY ACQUISITIONS (2019-2024)
  • TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 PERIODONTAL DISEASE TREATMENT: LIST OF MAJOR PATENTS
  • TABLE 14 US PERIODONTAL DISEASE TREATMENT AND SUPPLIES: EXPORTS, 2015-2022 (IN 000')
  • TABLE 15 US INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, DENTAL OR VETERINARY SCIENCES: EXPORTS, 2019-2022 (IN 000')
  • TABLE 16 PERIODONTAL DISEASE TREATMENT MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 17 KEY CONFERENCES & EVENTS, 2024
  • TABLE 18 AVERAGE COST OF PERIODONTAL DISEASE TREATMENT SYSTEMS, (2021-2023) (USD)
  • TABLE 19 AVERAGE COST RANGE OF PERIODONTAL DISEASE TREATMENT, BY REGION (2021-2023) (USD)
  • TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PERIODONTAL DISEASE TREATMENT
  • TABLE 21 PERIODONTAL DISEASE TREATMENT MARKET: UNMET NEEDS
  • TABLE 22 IMPACT OF AI/GEN AI ON PERIODONTAL DISEASE TREATMENT MARKET
  • TABLE 23 PERIODONTAL DISEASE TREATMENT MARKET: PREVALENCE OF GINGIVITIS, BY KEY COUNTRIES
  • TABLE 24 PERIODONTAL DISEASE TREATMENT MARKET: ANALYSIS OF TOTAL SURGERIES, BY KEY COUNTRY
  • TABLE 25 PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 26 PERIODONTAL DISEASE TREATMENT MARKET FOR EQUIPMENT, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 27 PERIODONTAL DISEASE TREATMENT MARKET FOR CONSUMABLES, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 28 PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 29 PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022-2030 (USD MILLION)
  • TABLE 30 GINGIVITIS MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 31 GINGIVITIS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 32 ACUTE GINGIVITIS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 33 RECURRENT GINGIVITIS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 34 CHRONIC GINGIVITIS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 35 CHRONIC PERIODONTITIS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 36 AGGRESSIVE PERIODONTITIS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 37 OTHER DISEASES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 38 PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022-2030 (USD MILLION)
  • TABLE 39 NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 40 NON-SURGICAL TREATMENT MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 41 NON-SURGICAL TREATMENT MARKET FOR SCALING, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 42 NON-SURGICAL TREATMENT MARKET FOR ROOT PLANING, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 43 NON-SURGICAL TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 44 NON-SURGICAL TREATMENT MARKET FOR MEDICATION THERAPY, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 45 TOPICAL THERAPY MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 46 SYSTEMIC THERAPY MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 47 FLAP SURGERY/POCKET REDUCTION THERAPY MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 48 SOFT TISSUE GRAFT MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 49 BONE GRAFTING MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 50 GUIDED TISSUE REGENERATION MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 51 OTHER TREATMENTS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 52 PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 53 LEADING DESTINATIONS FOR COST-EFFICIENT DENTAL TREATMENT
  • TABLE 54 PERIODONTAL DISEASE TREATMENT MARKET FOR HOSPITALS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 55 PERIODONTAL DISEASE TREATMENT MARKET FOR PRIVATE & DSO CLINICS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 56 PERIODONTAL DISEASE TREATMENT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 57 PERIODONTAL DISEASE TREATMENT MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 58 NORTH AMERICA: PERIODONTAL DISEASE TREATMENT MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 59 NORTH AMERICA: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 60 NORTH AMERICA: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022-2030 (USD MILLION)
  • TABLE 61 NORTH AMERICA: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 62 NORTH AMERICA: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022-2030 (USD MILLION)
  • TABLE 63 NORTH AMERICA: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 64 NORTH AMERICA: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 65 NORTH AMERICA: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 66 US: MACROECONOMIC INDICATORS
  • TABLE 67 US: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 68 US: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022-2030 (USD MILLION)
  • TABLE 69 US: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 70 US: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 71 US: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 72 US: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 73 US: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 74 CANADA: MACROECONOMIC INDICATORS
  • TABLE 75 CANADA: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 76 CANADA: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022-2030 (USD MILLION)
  • TABLE 77 CANADA: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 78 CANADA: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022-2030 (USD MILLION)
  • TABLE 79 CANADA: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 80 CANADA: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 81 CANADA: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 82 EUROPE: PERIODONTAL DISEASE TREATMENT MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 83 EUROPE: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 84 EUROPE: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022-2030 (USD MILLION)
  • TABLE 85 EUROPE: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 86 EUROPE: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022-2030 (USD MILLION)
  • TABLE 87 EUROPE: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 88 EUROPE: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 89 EUROPE: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 90 GERMANY: MACROECONOMIC INDICATORS
  • TABLE 91 GERMANY: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 92 GERMANY: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022-2030 (USD MILLION)
  • TABLE 93 GERMANY: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 94 GERMANY: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022-2030 (USD MILLION)
  • TABLE 95 GERMANY: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 96 GERMANY: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 97 GERMANY: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 98 FRANCE: MACROECONOMIC INDICATORS
  • TABLE 99 FRANCE: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 100 FRANCE: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022-2030 (USD MILLION)
  • TABLE 101 FRANCE: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 102 FRANCE: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 103 FRANCE: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 104 FRANCE: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 105 FRANCE: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 106 UK: MACROECONOMIC INDICATORS
  • TABLE 107 UK: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 108 UK: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022-2030 (USD MILLION)
  • TABLE 109 UK: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 110 UK: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022-2030 (USD MILLION)
  • TABLE 111 UK: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 112 UK: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 113 UK: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 114 ITALY: MACROECONOMIC INDICATORS
  • TABLE 115 ITALY: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 116 ITALY: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022-2030 (USD MILLION)
  • TABLE 117 ITALY: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 118 ITALY: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022-2030 (USD MILLION)
  • TABLE 119 ITALY: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 120 ITALY: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 121 ITALY: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 122 SPAIN: MACROECONOMIC INDICATORS
  • TABLE 123 SPAIN: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 124 SPAIN: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022-2030 (USD MILLION)
  • TABLE 125 SPAIN: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 126 SPAIN: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022-2030 (USD MILLION)
  • TABLE 127 SPAIN: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 128 SPAIN: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 129 SPAIN: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 130 REST OF EUROPE: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 131 REST OF EUROPE: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022-2030 (USD MILLION)
  • TABLE 132 REST OF EUROPE: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 133 REST OF EUROPE: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022-2030 (USD MILLION)
  • TABLE 134 REST OF EUROPE: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 135 REST OF EUROPE: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 136 REST OF EUROPE: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 137 ASIA PACIFIC: PERIODONTAL DISEASE TREATMENT MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 138 ASIA PACIFIC: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 139 ASIA PACIFIC: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022-2030 (USD MILLION)
  • TABLE 140 ASIA PACIFIC: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 141 ASIA PACIFIC: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022-2030 (USD MILLION)
  • TABLE 142 ASIA PACIFIC: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 143 ASIA PACIFIC: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 144 ASIA PACIFIC: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 145 CHINA: MACROECONOMIC INDICATORS
  • TABLE 146 CHINA: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 147 CHINA: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022-2030 (USD MILLION)
  • TABLE 148 CHINA: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 149 CHINA: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022-2030 (USD MILLION)
  • TABLE 150 CHINA: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 151 CHINA: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 152 CHINA: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 153 JAPAN: MACROECONOMIC INDICATORS
  • TABLE 154 JAPAN: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 155 JAPAN: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022-2030 (USD MILLION)
  • TABLE 156 JAPAN: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 157 JAPAN: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022-2030 (USD MILLION)
  • TABLE 158 JAPAN: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 159 JAPAN: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 160 JAPAN: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 161 INDIA: MACROECONOMIC INDICATORS
  • TABLE 162 INDIA: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 163 INDIA: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022-2030 (USD MILLION)
  • TABLE 164 INDIA: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 165 INDIA: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022-2030 (USD MILLION)
  • TABLE 166 INDIA: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 167 INDIA: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 168 INDIA: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 169 AUSTRALIA: MACROECONOMIC INDICATORS
  • TABLE 170 AUSTRALIA: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 171 AUSTRALIA: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022-2030 (USD MILLION)
  • TABLE 172 AUSTRALIA: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 173 AUSTRALIA: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022-2030 (USD MILLION)
  • TABLE 174 AUSTRALIA: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 175 AUSTRALIA: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 176 AUSTRALIA: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 177 SOUTH KOREA: MACROECONOMIC INDICATORS
  • TABLE 178 SOUTH KOREA: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 179 SOUTH KOREA: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022-2030 (USD MILLION)
  • TABLE 180 SOUTH KOREA: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 181 SOUTH KOREA: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022-2030 (USD MILLION)
  • TABLE 182 SOUTH KOREA: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 183 SOUTH KOREA: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 184 SOUTH KOREA: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 185 REST OF ASIA PACIFIC: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 186 REST OF ASIA PACIFIC: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022-2030 (USD MILLION)
  • TABLE 187 REST OF ASIA PACIFIC: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 188 REST OF ASIA PACIFIC: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022-2030 (USD MILLION)
  • TABLE 189 REST OF ASIA PACIFIC: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 190 REST OF ASIA PACIFIC: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 191 REST OF ASIA PACIFIC: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 192 LATIN AMERICA: PERIODONTAL DISEASE TREATMENT MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 193 LATIN AMERICA: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 194 LATIN AMERICA: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022-2030 (USD MILLION)
  • TABLE 195 LATIN AMERICA: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 196 LATIN AMERICA: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022-2030 (USD MILLION)
  • TABLE 197 LATIN AMERICA: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 198 LATIN AMERICA: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 199 LATIN AMERICA: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 200 MEXICO: MACROECONOMIC INDICATORS
  • TABLE 201 MEXICO: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 202 MEXICO: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022-2030 (USD MILLION)
  • TABLE 203 MEXICO: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 204 MEXICO: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022-2030 (USD MILLION)
  • TABLE 205 MEXICO: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 206 MEXICO: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 207 MEXICO: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 208 BRAZIL: MACROECONOMIC INDICATORS
  • TABLE 209 BRAZIL: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 210 BRAZIL: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022-2030 (USD MILLION)
  • TABLE 211 BRAZIL: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 212 BRAZIL: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022-2030 (USD MILLION)
  • TABLE 213 BRAZIL: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 214 BRAZIL: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 215 BRAZIL: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 216 ARGENTINA: MACROECONOMIC INDICATORS
  • TABLE 217 ARGENTINA: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 218 ARGENTINA: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022-2030 (USD MILLION)
  • TABLE 219 ARGENTINA: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 220 ARGENTINA: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022-2030 (USD MILLION)
  • TABLE 221 ARGENTINA: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 222 ARGENTINA: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 223 ARGENTINA: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 224 REST OF LATIN AMERICA: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 225 REST OF LATIN AMERICA: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022-2030 (USD MILLION)
  • TABLE 226 REST OF LATIN AMERICA: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 227 REST OF LATIN AMERICA: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022-2030 (USD MILLION)
  • TABLE 228 REST OF LATIN AMERICA: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 229 REST OF LATIN AMERICA: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 230 REST OF LATIN AMERICA: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 231 MIDDLE EAST & AFRICA: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 232 MIDDLE EAST & AFRICA: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022-2030 (USD MILLION)
  • TABLE 233 MIDDLE EAST & AFRICA: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 234 MIDDLE EAST & AFRICA: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022-2030 (USD MILLION)
  • TABLE 235 MIDDLE EAST & AFRICA: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 236 MIDDLE EAST & AFRICA: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 237 MIDDLE EAST & AFRICA: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 238 GCC COUNTRIES: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 239 GCC COUNTRIES: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022-2030 (USD MILLION)
  • TABLE 240 GCC COUNTRIES: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 241 GCC COUNTRIES: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022-2030 (USD MILLION)
  • TABLE 242 GCC COUNTRIES: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 243 GCC COUNTRIES: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 244 GCC COUNTRIES: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 245 PERIODONTAL DISEASE TREATMENT MARKET: DEGREE OF COMPETITION
  • TABLE 246 PERIODONTAL DISEASE TREATMENT MARKET: REGION FOOTPRINT
  • TABLE 247 PERIODONTAL DISEASE TREATMENT MARKET: PRODUCT FOOTPRINT
  • TABLE 248 PERIODONTAL DISEASE TREATMENT MARKET: DISEASE FOOTPRINT
  • TABLE 249 PERIODONTAL DISEASE TREATMENT MARKET: TREATMENT FOOTPRINT
  • TABLE 250 PERIODONTAL DISEASE TREATMENT MARKET: END-USER FOOTPRINT
  • TABLE 251 PERIODONTAL DISEASE TREATMENT MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
  • TABLE 252 PERIODONTAL DISEASE TREATMENT MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
  • TABLE 253 PERIODONTAL DISEASE TREATMENT MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-OCTOBER 2024
  • TABLE 254 PERIODONTAL DISEASE TREATMENT MARKET: DEALS, JANUARY 2021-OCTOBER 2024
  • TABLE 255 PERIODONTAL DISEASE TREATMENT MARKET: EXPANSIONS, JANUARY 2021-OCTOBER 2024
  • TABLE 256 DENTSPLY SIRONA: COMPANY OVERVIEW
  • TABLE 257 DENTSPLY SIRONA: PRODUCTS OFFERED
  • TABLE 258 DENTSPLY SIRONA: PRODUCT LAUNCHES, JANUARY 2021-OCTOBER 2024
  • TABLE 259 DENTSPLY SIRONA: DEALS, JANUARY 2021-OCTOBER 2024
  • TABLE 260 ENVISTA HOLDINGS CORPORATION: COMPANY OVERVIEW
  • TABLE 261 ENVISTA HOLDINGS CORPORATION: PRODUCTS OFFERED
  • TABLE 262 ENVISTA HOLDINGS CORPORATION: PRODUCT APPROVALS, JANUARY 2021-OCTOBER 2024
  • TABLE 263 ENVISTA HOLDINGS CORPORATION: DEALS
  • TABLE 264 INSTITUT STRAUMANN AG: COMPANY OVERVIEW
  • TABLE 265 INSTITUT STRAUMANN AG: PRODUCTS OFFERED
  • TABLE 266 INSTITUT STRAUMANN AG: PRODUCT LAUNCHES, JANUARY 2021-OCTOBER 2024
  • TABLE 267 INSTITUT STRAUMANN AG: DEALS, JANUARY 2021-OCTOBER 2024
  • TABLE 268 INSTITUT STRAUMANN AG: EXPANSIONS, JANUARY 2021-OCTOBER 2024
  • TABLE 269 HENRY SCHEIN, INC.: COMPANY OVERVIEW
  • TABLE 270 HENRY SCHEIN, INC.: PRODUCTS OFFERED
  • TABLE 271 HENRY SCHEIN, INC.: DEALS, JANUARY 2021-OCTOBER 2024
  • TABLE 272 BIOLASE INC.: COMPANY OVERVIEW
  • TABLE 273 BIOLASE INC.: PRODUCTS OFFERED
  • TABLE 274 BIOLASE INC.: PRODUCT LAUNCHES, JANUARY 2021-OCTOBER 2024
  • TABLE 275 GEISTLICH PHARMA AG: COMPANY OVERVIEW
  • TABLE 276 GEISTLICH PHARMA AG: PRODUCTS OFFERED
  • TABLE 277 J. MORITA CORP.: COMPANY OVERVIEW
  • TABLE 278 J. MORITA CORP.: PRODUCTS OFFERED
  • TABLE 279 J. MORITA CORP.: PRODUCT LAUNCHES, JANUARY 2021-OCTOBER 2024
  • TABLE 280 J. MORITA CORP.: DEALS, JANUARY 2021-OCTOBER 2024
  • TABLE 281 NAKANISHI INC.: COMPANY OVERVIEW
  • TABLE 282 NAKANISHI INC.: PRODUCTS OFFERED
  • TABLE 283 A-DEC INC.: COMPANY OVERVIEW
  • TABLE 284 A-DEC: PRODUCTS OFFERED
  • TABLE 285 RTI SURGICAL: COMPANY OVERVIEW
  • TABLE 286 RTI SURGICAL: PRODUCTS OFFERED
  • TABLE 287 RTI SURGICAL: DEALS, JANUARY 2021-OCTOBER 2024
  • TABLE 288 YOSHIDA DENTAL MFG.CO. LTD.: COMPANY OVERVIEW
  • TABLE 289 YOSHIDA DENTAL MFG.CO. LTD.: PRODUCTS OFFERED
  • TABLE 290 KEYSTONE DENTAL INC.: COMPANY OVERVIEW
  • TABLE 291 KEYSTONE DENTAL INC.: PRODUCTS OFFERED
  • TABLE 292 KEYSTONE DENTAL: DEALS, JANUARY 2021-OCTOBER 2024
  • TABLE 293 ULTRADENT PRODUCTS, INC.: COMPANY OVERVIEW
  • TABLE 294 ULTRADENT PRODUCTS, INC.: PRODUCTS OFFERED
  • TABLE 295 BEGO GMBH & CO. KG: COMPANY OVERVIEW
  • TABLE 296 BEGO GMBH & CO. KG: PRODUCTS OFFERED
  • TABLE 297 BEGO GMBH & CO. KG: DEALS, JANUARY 2021-OCTOBER 2024
  • TABLE 298 DENTALEZ INC.: COMPANY OVERVIEW
  • TABLE 299 DENTALEZ INC.: PRODUCTS OFFERED
  • TABLE 300 DENTALEZ INC.: PRODUCT LAUNCHES, JANUARY 2021-OCTOBER 2024
  • TABLE 301 PARKELL, INC.: COMPANY OVERVIEW
  • TABLE 302 PARKELL, INC.: PRODUCTS OFFERED
  • TABLE 303 PARKELL, INC.: PRODUCT LAUNCHES, JANUARY 2021-OCTOBER 2024

List of Figures

  • FIGURE 1 RESEARCH DESIGN
  • FIGURE 2 PRIMARY SOURCES
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
  • FIGURE 6 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 7 INSTITUT STRAUMANN AG: REVENUE SHARE ANALYSIS ILLUSTRATION
  • FIGURE 8 SUPPLY-SIDE ANALYSIS: PERIODONTAL DISEASE TREATMENT MARKET (2023)
  • FIGURE 9 PERIODONTAL DISEASE TREATMENT MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024-2030)
  • FIGURE 10 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 11 TOP-DOWN APPROACH
  • FIGURE 12 MARKET DATA TRIANGULATION METHODOLOGY
  • FIGURE 13 STUDY ASSUMPTIONS
  • FIGURE 14 PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2024 VS. 2030 (USD MILLION)
  • FIGURE 15 PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2024 VS. 2030 (USD MILLION)
  • FIGURE 16 PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2024 VS. 2030 (USD MILLION)
  • FIGURE 17 PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022 VS. 2029 (USD MILLION)
  • FIGURE 18 GEOGRAPHIC SNAPSHOT OF PERIODONTAL DISEASE TREATMENT MARKET
  • FIGURE 19 INCREASING PREVALENCE OF ORAL DISORDERS TO PROPEL MARKET
  • FIGURE 20 EQUIPMENT SEGMENT IN CHINA ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
  • FIGURE 21 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 22 NORTH AMERICA REGION TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 23 PERIODONTAL DISEASE TREATMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 24 TOTAL DENTAL ENROLLMENT (2011-2020)
  • FIGURE 25 VALUE CHAIN ANALYSIS
  • FIGURE 26 PERIODONTAL DISEASE TREATMENT MARKET: ECOSYSTEM MAP
  • FIGURE 27 PATENT PUBLICATION TRENDS (2013-2024)
  • FIGURE 28 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR PERIODONTAL DISEASE TREATMENT PATENTS (2013-2024)
  • FIGURE 29 TOP 10 APPLICANT COUNTRIES/REGIONS FOR PERIODONTAL DISEASE TREATMENT PATENTS (2013-2024)
  • FIGURE 30 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 31 ADJACENT MARKETS FOR PERIODONTAL DISEASE TREATMENT
  • FIGURE 32 PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 33 AVERAGE SELLING PRICE OF PERIODONTAL DISEASE TREATMENT, BY PRODUCT TYPE
  • FIGURE 34 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PERIODONTAL DISEASE TREATMENT
  • FIGURE 35 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PERIODONTAL DISEASE TREATMENT
  • FIGURE 36 PERIODONTAL DISEASE TREATMENT MARKET: INVESTMENT & FUNDING SCENARIO, 2021-2024
  • FIGURE 37 NORTH AMERICA: PERIODONTAL DISEASE TREATMENT MARKET SNAPSHOT
  • FIGURE 38 ASIA PACIFIC: PERIODONTAL DISEASE TREATMENT MARKET SNAPSHOT
  • FIGURE 39 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES
  • FIGURE 40 REVENUE ANALYSIS OF KEY PLAYERS IN PERIODONTAL DISEASE TREATMENT MARKET (2019-2023)
  • FIGURE 41 MARKET SHARE ANALYSIS OF KEY PLAYERS IN PERIODONTAL DISEASE TREATMENT MARKET (2023)
  • FIGURE 42 PERIODONTAL DISEASE TREATMENT MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 43 PERIODONTAL DISEASE TREATMENT MARKET: COMPANY FOOTPRINT
  • FIGURE 44 PERIODONTAL DISEASE TREATMENT MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 45 EV/EBITDA OF KEY VENDORS
  • FIGURE 46 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 47 PERIODONTAL DISEASE TREATMENT MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS, BY MODEL
  • FIGURE 48 R&D EXPENDITURE OF KEY PLAYERS IN PERIODONTAL DISEASE TREATMENT MARKET (2022 VS. 2023)
  • FIGURE 49 DENTSPLY SIRONA: COMPANY SNAPSHOT (2023)
  • FIGURE 50 ENVISTA HOLDINGS CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 51 INSTITUT STRAUMANN AG: COMPANY SNAPSHOT (2023)
  • FIGURE 52 HENRY SCHEIN, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 53 BIOLASE INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 54 NAKANISHI INC.: COMPANY SNAPSHOT (2023)